Core Global Portfolio Drives Takeda Despite Pockets Of Weakness

Entyvio Solid But Hematology More Challenging

Japanese firm raises full-year forecast for core operating profit on continued growth for global brands, despite US recall and hematology pressures.

Takeda Tokyo HQ entrance
Takeda Pleased With Post-Shire Progress • Source: Takeda

More from Business

More from Scrip